209 POSTER An open-label, multicenter, phase 1/2 study of...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

209 POSTER An open-label, multicenter, phase 1/2 study of AT-101 in combination with docetaxel and prednisone in men with hormone refractory prostate cancer

G. MacVicar, F.A. Greco, J. Reeves, B. Curti, B. Poiesz, B. Somer, K. Brill, L. Leopold
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72141-4
File:
PDF, 79 KB
english, 2008
Conversion to is in progress
Conversion to is failed